231 related articles for article (PubMed ID: 22228338)
21. Role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: A case series.
Albano D; Bosio G; Orlando E; Bertagna F
Hematol Oncol; 2017 Dec; 35(4):884-889. PubMed ID: 28004400
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
[TBL] [Abstract][Full Text] [Related]
23. Gastric mucosa-associated lymphoid tissue lymphoma: radiographic findings in six patients.
Yoo CC; Levine MS; Furth EE; Salhany KE; Rubesin SE; Laufer I; Herlinger H
Radiology; 1998 Jul; 208(1):239-43. PubMed ID: 9646819
[TBL] [Abstract][Full Text] [Related]
24.
Albano D; Durmo R; Treglia G; Giubbini R; Bertagna F
Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):137-146. PubMed ID: 32029397
[TBL] [Abstract][Full Text] [Related]
25. The role of baseline 2-[
Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
[TBL] [Abstract][Full Text] [Related]
26. 18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma.
Kim DH; Jeong JY; Lee SW; Lee J; Ahn BC
Clin Nucl Med; 2015 Feb; 40(2):e148-9. PubMed ID: 25140550
[TBL] [Abstract][Full Text] [Related]
27. Gastric mucosa-associated lymphoid tissue lymphoma: helical CT findings and pathologic correlation.
Choi D; Lim HK; Lee SJ; Lim JH; Kim SH; Lee WJ; Lee JH; Kim YH; Rhee PL; Kim JJ; Ko YH
AJR Am J Roentgenol; 2002 May; 178(5):1117-22. PubMed ID: 11959712
[TBL] [Abstract][Full Text] [Related]
28. Conjunctival lymphoma can be detected by FDG PET.
Matsuo T; Ichimura K; Tanaka T; Kaji M
Clin Nucl Med; 2012 May; 37(5):516-9. PubMed ID: 22475910
[TBL] [Abstract][Full Text] [Related]
29. Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Mayerhoefer ME; Karanikas G; Kletter K; Kiesewetter B; Weber M; Rausch I; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Nucl Med; 2016 Nov; 41(11):837-843. PubMed ID: 27648705
[TBL] [Abstract][Full Text] [Related]
30. Is narrow-band imaging useful for histological evaluation of gastric mucosa-associated lymphoid tissue lymphoma after treatment?
Nonaka K; Ohata K; Matsuhashi N; Shimizu M; Arai S; Hiejima Y; Kita H
Dig Endosc; 2014 May; 26(3):358-64. PubMed ID: 24118642
[TBL] [Abstract][Full Text] [Related]
31. F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid.
Mikosch P; Würtz FG; Gallowitsch HJ; Kresnik E; Lind P
Wien Med Wochenschr; 2003; 153(3-4):89-92. PubMed ID: 12658970
[TBL] [Abstract][Full Text] [Related]
32. CT, MRI, and 18F-FDG PET/CT Findings in Untreated Pulmonary and Hepatic B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Over a Five-Year Period: A Case Report.
Dong A; Xiao Z; Yang J; Zuo C
Medicine (Baltimore); 2016 Mar; 95(12):e3197. PubMed ID: 27015219
[TBL] [Abstract][Full Text] [Related]
33. Clinical study of 31 patients with primary gastric mucosa-associated lymphoid tissue lymphoma.
Hu C; Yi C; Dai X
J Gastroenterol Hepatol; 2006 Apr; 21(4):722-6. PubMed ID: 16677159
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsad M; Franchi R; Fanti S; Zinzani PL
Leuk Lymphoma; 2006 Oct; 47(10):2096-101. PubMed ID: 17071482
[TBL] [Abstract][Full Text] [Related]
35. F-18 FDG PET/CT findings in a patient with bilateral orbital and gastric mucosa-associated lymphoid tissue lymphomas.
Suga K; Yasuhiko K; Hiyama A; Takeda K; Matsunaga N
Clin Nucl Med; 2009 Sep; 34(9):589-93. PubMed ID: 19692819
[TBL] [Abstract][Full Text] [Related]
36. FDG avidity and PET/CT patterns in primary gastric lymphoma.
Radan L; Fischer D; Bar-Shalom R; Dann EJ; Epelbaum R; Haim N; Gaitini D; Israel O
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1424-30. PubMed ID: 18418594
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and review of the literature.
Bao C; Wei J; Zhao X; Lin L; Chen D; Liu K; Qian W; Anas JM; Zhao K
Medicine (Baltimore); 2018 Mar; 97(10):e9877. PubMed ID: 29517697
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary mucosa-associated lymphoid tissue type lymphoma with increased accumulation of fluorine 18-fluorodeoxyglucose on positron emission tomography.
Natsag J; Tomiyama N; Inoue A; Bryce TJ; Damdinsuren B; Honda O; Mihara N; Sumikawa H; Fujita S; Johkoh T; Hatazawa J; Nakamura H
J Comput Assist Tomogr; 2005; 29(5):640-3. PubMed ID: 16163034
[TBL] [Abstract][Full Text] [Related]
39. The role of
Wang W; Ni X; Tang T; Wang J; Li Y; Song X
Br J Radiol; 2022 Feb; 95(1130):20210635. PubMed ID: 34919440
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET/CT and primary hepatic MALT: a case series.
Albano D; Giubbini R; Bertagna F
Abdom Radiol (NY); 2016 Oct; 41(10):1956-9. PubMed ID: 27259334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]